Alfacalcidol: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
illustration is added
Fixed the effect of calcitriol and alfacalcidiol on PTH, which was inverted. Also fixed link to study.
Line 49: Line 49:
'''Alfacalcidol''' (or '''1-hydroxycholecalciferol''') is an analogue of [[vitamin D]] used for supplementation in humans and as a poultry feed additive.
'''Alfacalcidol''' (or '''1-hydroxycholecalciferol''') is an analogue of [[vitamin D]] used for supplementation in humans and as a poultry feed additive.


Alfacalcidol has a weaker impact on [[calcium metabolism]] than [[calcitriol]],<ref>Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women, Clin Cases Miner Bone Metab. 2009 May–Aug; 6(2): 169–173; [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781231/]</ref> while having more potent effects on [[parathyroid hormone]] levels<ref>Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial, Can J ,Clin Pharmacol Vol 15 (1) Winter 2008:e36 -e43; January 9, 2008; [http://www.cjcp.ca/cjcp07017_wazny_e36-e43v2-r101690]</ref> and the [[immune system]], including [[regulatory T cells]].<ref>Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease, Autoimmunity Reviews, August 2010;</ref> It is considered{{by whom|date=September 2012}} to be a more useful form of [[vitamin D]] supplementation, mostly due to much longer half-life and lower kidney load.<ref>Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis, Rheumatol Int. 2006 Mar;26(5):445-53. Epub 2005 Nov 10; [http://www.ncbi.nlm.nih.gov/pubmed/16283320]</ref>
Alfacalcidol has a weaker impact on [[calcium metabolism]] than [[calcitriol]],<ref>Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women, Clin Cases Miner Bone Metab. 2009 May–Aug; 6(2): 169–173; [http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781231/]</ref> and on [[parathyroid hormone]] levels<ref>Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial, Can J ,Clin Pharmacol Vol 15 (1) Winter 2008:e36 -e43; January 9, 2008; [http://www.jptcp.com/cjcp07017_wazny_e36-e43v2-r101690]</ref>, however alfacalcidiol has significant effects on the [[immune system]], including [[regulatory T cells]].<ref>Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease, Autoimmunity Reviews, August 2010;</ref> It is considered{{by whom|date=September 2012}} to be a more useful form of [[vitamin D]] supplementation, mostly due to much longer half-life and lower kidney load.<ref>Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis, Rheumatol Int. 2006 Mar;26(5):445-53. Epub 2005 Nov 10; [http://www.ncbi.nlm.nih.gov/pubmed/16283320]</ref>


Used as a poultry feed additive, it prevents [[tibial dyschondroplasia]] and increases [[phytate]] bioavailability.<ref>[http://www.vitaminderivatives.com VDI Product Data]</ref>{{or|date=October 2010}}
Used as a poultry feed additive, it prevents [[tibial dyschondroplasia]] and increases [[phytate]] bioavailability.<ref>[http://www.vitaminderivatives.com VDI Product Data]</ref>{{or|date=October 2010}}

Revision as of 08:25, 4 December 2013

Alfacalcidol
Names
IUPAC name
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-Methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
Other names
Alphacalcidol; 1-Hydroxycholecalciferol
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard 100.050.253 Edit this at Wikidata
KEGG
UNII
  • InChI=1S/C27H44O2/c1-18(2)8-6-9-19(3)24-13-14-25-21(10-7-15-27(24,25)5)11-12-22-16-23(28)17-26(29)20(22)4/h11-12,18-19,23-26,28-29H,4,6-10,13-17H2,1-3,5H3/b21-11+,22-12-/t19-,23-,24-,25+,26+,27-/m1/s1 checkY
    Key: OFHCOWSQAMBJIW-AVJTYSNKSA-N checkY
  • InChI=1/C27H44O2/c1-18(2)8-6-9-19(3)24-13-14-25-21(10-7-15-27(24,25)5)11-12-22-16-23(28)17-26(29)20(22)4/h11-12,18-19,23-26,28-29H,4,6-10,13-17H2,1-3,5H3/b21-11+,22-12-/t19-,23-,24-,25+,26+,27-/m1/s1
    Key: OFHCOWSQAMBJIW-AVJTYSNKBM
  • O[C@@H]1CC(\C(=C)[C@@H](O)C1)=C\C=C2/CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C
Properties
C27H44O2
Molar mass 400.64 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Alfacalcidol (or 1-hydroxycholecalciferol) is an analogue of vitamin D used for supplementation in humans and as a poultry feed additive.

Alfacalcidol has a weaker impact on calcium metabolism than calcitriol,[1] and on parathyroid hormone levels[2], however alfacalcidiol has significant effects on the immune system, including regulatory T cells.[3] It is considered[by whom?] to be a more useful form of vitamin D supplementation, mostly due to much longer half-life and lower kidney load.[4]

Used as a poultry feed additive, it prevents tibial dyschondroplasia and increases phytate bioavailability.[5][original research?]

References

  1. ^ Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women, Clin Cases Miner Bone Metab. 2009 May–Aug; 6(2): 169–173; [1]
  2. ^ Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial, Can J ,Clin Pharmacol Vol 15 (1) Winter 2008:e36 -e43; January 9, 2008; [2]
  3. ^ Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease, Autoimmunity Reviews, August 2010;
  4. ^ Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis, Rheumatol Int. 2006 Mar;26(5):445-53. Epub 2005 Nov 10; [3]
  5. ^ VDI Product Data